Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population

Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population

Abstract Cardiometabolic risk increases cardiovascular (CVD), chronic kidney (CKD) and non-alcoholic fatty liver (NAFLD) disease risk. High myeloperoxidase (MPO) levels identify individuals at risk for CVD. We whether elevation of MPO associated with kidney and liver disease risk in subgroups strati...

Full description

Saved in:
Bibliographic Details
Main Authors: Olga A. Iakoubova, Farnoosh Haji-Sheikhi, Judy Z. Louie, Charles M. Rowland, Andre R. Arellano, Lance A. Bare, Charles E. Birse, Marc S. Penn
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Myeloperoxidase
eGFR
Liver fibrosis
Online Access:https://doi.org/10.1038/s41598-025-89373-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-89373-7

Similar Items